Cargando…

EGFR-AS1/HIF2A regulates the expression of FOXP3 to impact the cancer stemness of smoking-related non-small cell lung cancer

BACKGROUND: Early data showed that FOXP3 could induce epithelial-mesenchymal transition by stimulating the Wnt/β-catenin signaling pathway in non-small cell lung cancer (NSCLC). However, how the expression of FOXP3 is regulated in NSCLC remains unknown. We thus explored the impacts of the long nonco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Haolong, Wang, Shanshan, Wu, Juekun, Yang, Shucai, Gray, Steven, Ng, Calvin S.H., Du, Jing, Underwood, Malcolm J., Li, Ming-Yue, Chen, George G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6598324/ https://www.ncbi.nlm.nih.gov/pubmed/31275431 http://dx.doi.org/10.1177/1758835919855228

Ejemplares similares

FOXP3 promotes tumor growth and metastasis by activating Wnt/β-catenin signaling pathway and EMT in non-small cell lung cancer
por: Yang, Shucai, et al.
Publicado: (2017)

Gene expression changes with a 'non-injurious' ventilation strategy
por: Ng, Calvin SH, et al.
Publicado: (2009)

Isolation of circulating tumor cells and detection of EGFR mutations in patients with non-small-cell lung cancer
por: Zhang, Qi, et al.
Publicado: (2019)

Cigarette smoke enhances oncogene addiction to c‐MET and desensitizes EGFR‐expressing non‐small cell lung cancer to EGFR TKIs
por: Tu, Chih‐Yen, et al.
Publicado: (2018)

Ambient fine particulate matter inhibits 15-lipoxygenases to promote lung carcinogenesis
por: Li, Ming-Yue, et al.
Publicado: (2019)

IL-1β induced HIF-1α inhibits the differentiation of human FOXP3(+) T cells
por: Feldhoff, Lea M., et al.
Publicado: (2017)

Foxp3 enhances HIF-1α target gene expression in human bladder cancer through decreasing its ubiquitin-proteasomal degradation
por: Jou, Yeong-Chin, et al.
Publicado: (2016)

EGFR in enterocytes & endothelium and HIF1α in enterocytes are dispensable for massive small bowel resection induced angiogenesis
por: Onufer, Emily J., et al.
Publicado: (2020)

Targeting lung cancer with clinically relevant EGFR mutations using anti-EGFR RNA aptamer
por: Thomas, Brian J., et al.
Publicado: (2023)

Smoking habit and chemo-radiotherapy and/or surgery affect the sensitivity of EGFR plasma test in non-small cell lung cancer
por: Tran, Vinh Thanh, et al.
Publicado: (2020)

HIF2α contributes to antiestrogen resistance via positive bilateral crosstalk with EGFR in breast cancer cells
por: Alam, Muhammad Wasi, et al.
Publicado: (2016)

A novel epigenetic regulation of circFoxp1 on Foxp1 in colon cancer cells
por: Luo, Yanwei, et al.
Publicado: (2020)

The effect of foxp3-overexpressing Treg cells on non-small cell lung cancer cells
por: Peng, Jiangzhou, et al.
Publicado: (2018)

Association between cigarette smoking history, metabolic phenotypes, and EGFR mutation status in patients with non-small cell lung cancer
por: Zhang, Xiaohui, et al.
Publicado: (2023)

Pharmacogenomics of EGFR-targeted therapies in non–small cell lung cancer: EGFR and beyond
por: Delaney, Christopher, et al.
Publicado: (2015)

Foxp3 expression in human cancer cells
por: Karanikas, Vaios, et al.
Publicado: (2008)

CT Radiomics in Predicting EGFR Mutation in Non-small Cell Lung Cancer: A Single Institutional Study
por: Wu, Shanshan, et al.
Publicado: (2020)

1, 9-Pyrazoloanthrones Downregulate HIF-1α and Sensitize Cancer Cells to Cetuximab-Mediated Anti-EGFR Therapy
por: Lu, Yang, et al.
Publicado: (2010)

Triple therapy with osimertinib, bevacizumab and cetuximab in EGFR-mutant lung cancer with HIF-1α/TGF-α expression
por: Nishii, Kazuya, et al.
Publicado: (2021)

EGFR T790M mutation after chemotherapy for small cell lung cancer transformation of EGFR-positive non-small cell lung cancer
por: Sonoda, Tomoaki, et al.
Publicado: (2018)

LAPS score for individualized treatment of advanced EGFR-mutated non-small cell lung cancer receiving EGFR-TKIs with or without bevacizumab
por: Wu, Yahua, et al.
Publicado: (2023)

Alveolar rhabdomyosarcoma of the anterior mediastinum with vessel invasion in a 4-month-old boy: a case report
por: Chow, Simon C.Y., et al.
Publicado: (2015)

EGFR-Targeted Therapy for Non-Small Cell Lung Cancer: Focus on EGFR Oncogenic Mutation
por: Antonicelli, Alberto, et al.
Publicado: (2013)

Impact of Sex and Smoking on the Efficacy of EGFR-TKIs in Terms of Overall Survival in Non-small-Cell Lung Cancer: A Meta-Analysis
por: Xiao, Jian, et al.
Publicado: (2020)

Ex-Th17 Foxp3+ T cells - a novel subset of Foxp3+ T cells induced in cancer
por: Downs-Canner, Stephanie, et al.
Publicado: (2015)

Nuclear galectin-1-FOXP3 interaction dampens the tumor-suppressive properties of FOXP3 in breast cancer
por: Gao, Yuan, et al.
Publicado: (2018)

Resistance to Both Chemotherapy and EGFR-TKI in Small Cell Lung Cancer With EGFR 19-Del Mutation: A Case Report
por: Wang, Lingfei, et al.
Publicado: (2020)

Radiotherapy with continued EGFR‐TKIs for oligoprogressive disease in EGFR‐mutated non‐small cell lung cancer: A real‐world study
por: Hu, Chunhong, et al.
Publicado: (2022)

Application of ddPCR in detection of the status and abundance of EGFR T790M mutation in the plasma samples of non-small cell lung cancer patients
por: Zhang, Hui, et al.
Publicado: (2023)

Targeting EGFR in Esophagogastric Cancer
por: Maron, Steven B., et al.
Publicado: (2020)

Toward the next generation EGFR inhibitors: an overview of osimertinib resistance mediated by EGFR mutations in non-small cell lung cancer
por: Li, Yufeng, et al.
Publicado: (2023)

FOXP2 confers oncogenic effects in prostate cancer
por: Zhu, Xiaoquan, et al.
Publicado: (2023)

Targeted EGFR Nanotherapy in Non-Small Cell Lung Cancer
por: Crintea, Andreea, et al.
Publicado: (2023)

FOXP3 Isoforms Expression in Cervical Cancer: Evidence about the Cancer-Related Properties of FOXP3Δ2Δ7 in Keratinocytes
por: Garcia-Becerra, Natalia, et al.
Publicado: (2023)

FOXP3(+) Lymphocyte Density in Pancreatic Cancer Correlates with Lymph Node Metastasis
por: Jiang, Yongjian, et al.
Publicado: (2014)

Low EGFR/MET ratio is associated with resistance to EGFR inhibitors in non-small cell lung cancer
por: Park, Silvia, et al.
Publicado: (2015)

Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non‐small cell lung cancer
por: Ali, Azhar, et al.
Publicado: (2018)

Which is better, EGFR-TKI mono or combination for non-small cell lung cancer with mutated EGFR?
por: Tanzawa, Shigeru, et al.
Publicado: (2019)

Expression of EGFR-mutant proteins and genomic evolution in EGFR-mutant transformed small cell lung cancer
por: Zhang, Shi-Ling, et al.
Publicado: (2023)

Cancer-FOXP3 directly activated CCL5 to recruit FOXP3(+)Treg cells in pancreatic ductal adenocarcinoma
por: Wang, X, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_be154476egt0fr97b4mrek67hp